Status:
ENROLLING_BY_INVITATION
MIO-CPP to Improve the Well-being, Permanency, and Safety Outcomes for Young Children at Risk of or in Out-of-home Placement in Philadelphia and Bucks Counties, and Affected by Maternal Substance Use
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Health Federation of Philadelphia
Libertae, Inc.
Conditions:
Substance Use Disorders
Parent-Child Relations
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The goal of the project is to improve child well-being, permanency, and safety, and reduce the risk for involvement in the child welfare system for families with children pre-birth to five years who a...
Eligibility Criteria
Inclusion
- Women actively receiving treatment for Substance Use Disorder at one of three participating residential substance use disorder clinics in Philadelphia and Bucks Counties (Libertae Inc.; Gaudenzia's Hutchinson House; Gaudenzia Winner Program).
- Must be at least six months pregnant or must have a child 5 years old or younger.
- Must have access to child - children must either reside with mother, or, if the child is in foster/kinship care, the goal must be reunification.
Exclusion
- Duration of affiliation with treatment center:
- Women will not be referred for enrollment before they have been affiliated with the treatment facility for at least 14 days and will not be referred if they are less than 45 days from discharge.
- These limitations will ensure that women are not referred to our study too quickly as they are adjusting to residential treatment, but will also ensure that we do not enroll women too soon before they are discharged from residential treatment.
- Non-English Speaking The study will not enroll mothers who would be unable to receive the intervention services in English without the assistance of an interpreter. Due to the duration of the study intervention as well as the frequency of visits between the Child-Parent Specialist and the client, it would not be feasible to ensure that an interpreter would also be available for all visits.
Key Trial Info
Start Date :
January 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04294134
Start Date
January 2 2020
End Date
September 30 2027
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roberts Center for Pediatric Research
Philadelphia, Pennsylvania, United States, 19146